RxSight, Inc. (RXST) Deferred Tax Assets, Valuation Allowance USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
RxSight, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2020 to 2023.
  • RxSight, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $103 M, a 14.1% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $103 M +$12.8 M +14.1% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $90.5 M +$14.9 M +19.8% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $75.5 M +$13.2 M +21.2% Dec 31, 2021 10-K 2023-03-06
Q4 2020 $62.4 M Dec 31, 2020 10-K 2022-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.